Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
Titel:
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
Auteur:
Inzucchi, Silvio E Claggett, Brian L Vaduganathan, Muthiah Desai, Akshay S Jhund, Pardeep S de Boer, Rudolf A Hernandez, Adrian F Kosiborod, Mikhail N Lam, Carolyn S P Martinez, Felipe Shah, Sanjiv J Verma, Subodh Han, Yaling Kerr Saraiva, Jose F Bengtsson, Olof Petersson, Magnus Langkilde, Anna Maria McMurray, John J V Solomon, Scott D